·         Cell and Molecular Biologist with a robust background in translational research, specializing in identifying novel molecular biomarkers, drug targets, and mechanism of action for advancing early cancer diagnosis and targeted cancer treatment. ·         Recognized for a proven track record of scientific innovation, evidenced by: ○        15+ scientific papers (6 as first/co-first author) having direct clinical development implications; 800+ citations. ○        20+ new collaborations; Presentations of scientific data in 10+ national/international conferences. ○        $350,000 as personal grant award acquisition from 10 foundations. ·         Exemplary collaborator and communicator with deep expertise in latest culture models, molecular biology techniques, assay development and Good Laboratory Practice (GLP). Demonstrated ability to effectively manage multiple projects, exhibiting exceptional organizational skills and keen attention to detail, leveraging innovative thinking to drive research forward. ·         Certified Medical Affairs Specialist with an understanding of clinical study and trials, contributing to regulatory submissions and fostering relationships with Key Opinion Leaders (KOLs), Contract Research Organizations (CROs), and other key stakeholders.